Press Releases on August 14, 2023 - EIN Presswire - Press Release Distribution Service

Published on August 14, 2023 - 20:05 GMT

Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

- Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Progressing as Planned with Nearly 30 Sites Now Open - - Proprietary Suprachoroidal Injection Platform Featured in Peer-Reviewed Publication and at ARVO, ASRS and OIS Scientific Meetings - - Management to Host …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on August 14, 2023 - 20:05 GMT

ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights

New data from Part A of Phase 2b/3 trial of izokibep in Hidradenitis Suppurativa demonstrated improvements in number of draining tunnels in two-thirds of patients as early as week 4; the placebo-controlled Part B remains on track for top-line data in the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Mavacamten New Drug Application (NDA) under priority review with China National Medical Products Administration (NMPA) Phase 3 EXPLORER-CN trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) met primary …

Distribution channels: Business & Economy, Technology ...

Published on August 14, 2023 - 20:05 GMT

联拓生物发布2023年第二季度财务业绩数据及公司近期经营动态

中国国家药品监督管理局（NMPA）正在对mavacamten的新药上市申请（NDA）进行优先审评 Mavacamten在中国有症状的梗阻性肥厚型心肌病（oHCM）患者中开展的EXPLORER-CN III期临床研究达到主要终点 EXPLORER-CN研究数据将在2023年欧洲心脏病学会年会Late-Breaking专场进行口头公布现金、现金等价物和有价证券等总计2.673亿美元，足以满足公司至2025年上半年的运营需求上海和新泽西州普林斯顿, Aug. 15, 2023 (GLOBE NEWSWIRE) …

Distribution channels: Business & Economy, Technology ...

Published on August 14, 2023 - 20:05 GMT

Nogin Reports Second Quarter 2023 Financial and Operational Results

New Services Business Customers Expected to Drive Revenue Growth and Adjusted EBITDA Management Implementing Business Portfolio Optimization and Margin Enhancement Initiatives TUSTIN, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Nogin, Inc. (Nasdaq: NOGN, …

Distribution channels: Business & Economy, Technology ...

Published on August 14, 2023 - 20:05 GMT

Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Cash runway projected into first quarter 2026 based on capital conservation measures implemented without impact to clinical development pipeline Technology transfer agreement executed for Company’s tumor penetrating nanocomplex (TPN) platform Company to …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

Beam Global Announces Record Second Quarter 2023 Operating Results

379% Quarterly Revenue Growth Year-Over-Year 312% First Half Revenue Growth Year-Over-Year 589% EV ARC™ Deployment Growth Year-Over-Year $23.7 Million in Cash and $37.1 Million in Working Capital LOI to Enter European Market with Acquisition of Amiga DOO …

Distribution channels: Business & Economy, Energy Industry ...

Published on August 14, 2023 - 20:05 GMT

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2023 Results on August 28, 2023

SALT LAKE CITY, Aug. 14, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its fourth …

Distribution channels: Consumer Goods ...

Published on August 14, 2023 - 20:05 GMT

CEA Industries Inc. Reports Second Quarter 2023 Results and Initiates Review of Strategic Alternatives

- Management to Host Conference Call Today at 4:15pm E.T. - Louisville, Colorado, Aug. 14, 2023 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), is reporting results for the three months ended June 30, 2023 …

Distribution channels: Technology ...

Published on August 14, 2023 - 20:05 GMT

Venus Concept Announces Second Quarter of Fiscal Year 2023 Financial Results

TORONTO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2023. Second Quarter 2023 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

Definitive Healthcare expands Atlas Technology Install Dataset

FRAMINGHAM, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has significantly expanded the technology installation data within its Atlas Dataset. In …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on August 14, 2023 - 20:05 GMT

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023

FRAMINGHAM, Mass., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June …

Distribution channels: Business & Economy, IT Industry ...

Published on August 14, 2023 - 20:05 GMT

SomaLogic Reports Second Quarter 2023 Financial Results

Revenue of $20.5 million, an increase of 45% year-over-year Cash and investments of approximately $474 million, a strong capital position to fund current and future business initiatives Reiterating full year 2023 revenue guidance and operating expense …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results

Initial Data from Phase 1 Multiple-Ascending Dose Trial of DT-216 for Friedreich Ataxia Showed Significant Increase in FXN mRNA Levels in Skeletal Muscle Company Expects to Resume a Multiple Dose Phase 1 Clinical Study with DT-216 with an Improved …

Distribution channels: Business & Economy, Technology ...

Published on August 14, 2023 - 20:05 GMT

GEN Restaurant Group, Inc. Announces Second Quarter 2023 Financial Results

CERRITOS, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a fast-growing cook-it-yourself casual dining concept, today announced financial results for the second quarter …

Distribution channels: Business & Economy ...

Published on August 14, 2023 - 20:05 GMT

Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company

Negotiating multiple LOIs to divest Orthopedic business CanGaroo® RM 510(k) resubmission to the FDA remains on track SimpliDerm® quarterly net sales up 32% year-over-year Successful transfer of Cardiovascular product distribution to LeMaitre Vascular …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year

LANGHORNE, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced financial …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

Viewbix Reports its Consolidated Financial Results for the First Half and the Second Quarter of 2023 with Revenues Totaling $48 ...

Ramat Gan, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Viewbix Inc. (OTC: VBIX) (“Viewbix” or the “Company”), a global developer of mar-tech and ad-tech innovative technologies, today announced its consolidated financial results for the first half and the …

Distribution channels: Technology ...

Published on August 14, 2023 - 20:05 GMT

Sanara MedTech Inc. Announces Second Quarter 2023 Results

FORT WORTH, TX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 14, 2023 - 20:05 GMT

RYVYL Reports Second Quarter 2023 Financial Results

Record Q2 Revenues Increase 113% to $14.8 million, Exceeding Guidance Range of $12 to $14.5 million Raises Q3 Revenue Outlook to $16 to $18 million; 2023 Full Year Revenue Expected to Exceed $60 million SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- …

Distribution channels: Banking, Finance & Investment Industry ...